C92.02
Billable
Acute myeloblastic leukemia, in relapse
C92.02 is billable and can be used for reimbursement purposes.
AI Search
Analyze diagnoses and doctors notes
Acute myeloblastic leukemia, in relapse
C92.02 is billable and can be used for reimbursement purposes.